
Sign up to save your podcasts
Or
Dr Tiffany Richards from The University of Texas MD Anderson Cancer Center in Houston discusses the current and emerging role of bispecific antibodies in the treatment of multiple myeloma.
NCPD information and select publications here.
4.9
99 ratings
Dr Tiffany Richards from The University of Texas MD Anderson Cancer Center in Houston discusses the current and emerging role of bispecific antibodies in the treatment of multiple myeloma.
NCPD information and select publications here.
17 Listeners
31 Listeners
16 Listeners
62 Listeners
4 Listeners
2 Listeners
12 Listeners
73 Listeners
0 Listeners
110 Listeners